In the U.S., cases are now higher in 45 states and have more than doubled in seven.
China is scaling back its daily COVID reporting as the end of mass PCR testing and the decision to allow people with mild symptoms to recover at home make it more difficult for the government to accurately track cases.
The government said Wednesday it would stop reporting asymptomatic COVID cases, as they have become “impossible” to track without mass testing, the Associated Press reported. China reported just 2,249 “confirmed” infections on Wednesday, bringing the nation’s official total over the course of the pandemic to 369,918 — more than double the number on Oct. 1. It has recorded 5,235 deaths, compared with 1.1 million in the United States. China’s official numbers are widely held to have been massively underreported since the beginning of the pandemic.
Cases are rising in 45 states, led by Oklahoma, where they have climbed 211% from two weeks ago; Georgia, where they are up 145%; Nevada, where they are up 119%; and South Carolina, where they are up 114%.The U.S. average for hospitalizations is up 22% to 38,732, led by Vermont, where they are up 69% in two weeks.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China stops publishing asymptomatic COVID cases, reports no deathsChina's National Health Commission (NHC) will as of Wednesday stop reporting new asymptomatic COVID-19 infections, as many people without symptoms no longer participate in testing, making it hard to accurately tally the total count, it said.
Read more »
Why people in China are panic buying canned yellow peaches as Covid surges | CNN BusinessAn unprecedented wave of Covid cases in China has sparked panic buying of fever medicines, pain killers, and even home remedies such as canned peaches, leading to shortages online and in stores.
Read more »
China deletes COVID tracking app as reopening gathers pacePeople in China celebrated the withdrawal on Tuesday of a state-mandated app used to track whether they had travelled to COVID-stricken areas, in the latest loosening of some of the world's toughest anti-virus rules.
Read more »
China health app starts online sales of Pfizer's Paxlovid for COVID treatmentA Chinese healthcare platform has started selling Pfizer's oral COVID treatment pill Paxlovid in what appears to be the first retail sale of the drug in the country, as China braces for a surge in COVID patients.
Read more »